In focus · trending topic

Gene editing

16 stories · following the connections

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

By Nasdaq OMXMar 28, 2017, 12:01 PM UTC

CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation

By Nasdaq OMXFeb 28, 2017, 1:01 PM UTC

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology

By Nasdaq OMXDec 16, 2016, 1:00 PM UTC

Scientists Made CRISPR Gene-Editing Tool Impotent, Ownership Battle In The Works

By Melvin Alfred WongDec 9, 2016, 11:32 AM UTC

China Creating Mutated Humans Now Using Revolutionary CRISPR Method

By Melvin Alfred WongNov 17, 2016, 10:00 AM UTC

CRISPR Therapeutics to Present at the Stifel 2016 Healthcare Conference

By Nasdaq OMXNov 8, 2016, 1:00 PM UTC

CRISPR Therapeutics Announces Pricing of Initial Public Offering

By Nasdaq OMXOct 19, 2016, 2:00 AM UTC

Poseida Therapeutics Establishes Scientific Advisory Board

By Nasdaq OMXSep 8, 2016, 11:30 AM UTC